These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10029088)

  • 21. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basis for the differential modulation of the uptake of 5-iododeoxyuridine by 5'-aminothymidine among various cell types.
    Vazquez-Padua MA; Fischer PH; Christian BJ; Reznikoff CA
    Cancer Res; 1989 May; 49(9):2415-21. PubMed ID: 2706629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells.
    Chattopadhyay S; Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(23):7986-93. PubMed ID: 15585634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
    Scanlon KJ; Kashani-Sabet M; Sowers LC
    Cancer Commun; 1989; 1(4):269-75. PubMed ID: 2534792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
    Weber G; Nagai M; Prajda N; Nakamura H; Szekeres T; Olah E
    Cancer Commun; 1991 Apr; 3(4):127-32. PubMed ID: 2025497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD; Smith AK; Kamen BA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
    Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
    Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.
    Konopka K; Fallah B; Monzon-Duller J; Overlid N; Düzgünes N
    Cell Mol Biol Lett; 2005; 10(3):455-70. PubMed ID: 16217556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine.
    Savaraj N; Wu C; Wangpaichitr M; Kuo MT; Lampidis T; Robles C; Furst AJ; Feun L
    Int J Oncol; 2003 Jul; 23(1):173-9. PubMed ID: 12792791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudine.
    Turriziani O; Scagnolari C; Bambacioni F; Bellomi F; Focher F; Gentile M; Antonelli G
    Antivir Ther; 2002 Jun; 7(2):105-11. PubMed ID: 12212922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro study of the modification by bleomycin of thymidine phosphorylation activity in lectin-stimulated normal human lymphocytes.
    Sharif A; Goussault Y
    Cancer Biochem Biophys; 1988 Jul; 10(1):17-24. PubMed ID: 2465077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of DNA polymerase beta sensitizes mammalian cells to 2',3'-deoxycytidine and 3'-azido-3'-deoxythymidine.
    Bouayadi K; Hoffmann JS; Fons P; Tiraby M; Reynes JP; Cazaux C
    Cancer Res; 1997 Jan; 57(1):110-6. PubMed ID: 8988050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene.
    Gröschel B; Höver G; Doerr HW; Cinatl J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):487-92. PubMed ID: 11563064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    Fischer PH; Weddle MA; Mossie RD
    Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of thymidine kinase activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakao M; Miki T
    J Urol; 2003 Feb; 169(2):706-9. PubMed ID: 12544347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
    Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthetase and thymidine kinase activities and methotrexate cytotoxicity during growth of L1210 and Ehrlich ascites tumor.
    Hullán L; Szikla K; Tusnády G; Holczinger L
    Cancer Biochem Biophys; 1988 Nov; 10(2):131-9. PubMed ID: 3252959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
    Mineishi S; Nakahara S; Takebe N; Zhao SC; Banerjee D; Bertino JR
    Cancer Gene Ther; 1998; 5(3):144-9. PubMed ID: 9622097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.